Cost|Effectiveness of Multigene Testing for Breast and Ovarian Cancer

Cost-Effectiveness of Multigene Testing for Breast and Ovarian Cancer

Population-based testing was a more cost-effective strategy for the prevention of breast cancer and ovarian cancer when compared with the current family ...

Cost-Effectiveness of Population-Based Multigene Testing for Breast ...

Cost-Effectiveness of Population-Based Multigene Testing for Breast and ... and Ovarian Cancer Prevention. JAMA Netw Open. 2024 Feb 5;7(2):e2356078. doi: ...

Cost-Effectiveness of Population-Based Multigene Testing for Breast ...

Compared with the current standard of care, which is family history–based testing, population-based testing led to fewer breast and ovarian ...

Cost-effectiveness of Multigene Testing for All Patients With Breast ...

One year's unselected panel genetic testing could prevent 2101 cases of breast or ovarian cancer and 633 deaths in the United Kingdom and 9733 ...

Cost-Effectiveness of Targeted Genetic Testing for Breast and ...

Compared with BRCA alone, (3) multigene testing in women without cancer had an ICER of $51 800/QALY (one study), while for (4) multigene-cascade screening the ...

Multigene Testing Offers Cost-Effectiveness, Broader Approach to ...

A large US study showed population-based multigene testing might be a cost-effective way to identify women at risk for breast and ovarian cancer.

Cost-effectiveness analyses of population-based multi-gene testing ...

Conclusions: Population-based multi-gene testing is a more cost-effective option for the prevention of breast cancer and ovarian cancer when compared to current ...

A Multigene Test Could Cost-Effectively Help Extend Life ...

Pathogenic variants can be detected in women with a family history of breast or ovarian cancer syndromes by multigene panel testing. Objectives: To investigate.

The Cost-Effectiveness of Multigene Panel Testing for Hereditary ...

At a cost-effectiveness threshold of $77,000, a 7-gene panel test with five non-BRCA genes was the optimal strategy with an incremental cost- ...

Multigene Testing of Everyone Diagnosed With Breast Cancer ...

A study found testing all people diagnosed with breast cancer for mutations in three genes linked to a high risk of the disease (BRCA1, ...

Cost-Effectiveness of BRCA 1/2 Genetic Test and Preventive ...

The BRCA1/2 genetic test and preventive strategies result in more quality-adjusted life years (QALYs) and costs with an incremental cost-effectiveness ratio of ...

A review of the cost-effectiveness of genetic testing for germline ...

Our evaluation of economic studies in breast and ovarian cancer, however, suggests that genetic testing is cost-effective across a wide variety of situations ...

Cost-Effectiveness of Genetic Testing for All Women Diagnosed with ...

FH/clinical-criteria-based BRCA testing was ruled out on the principle of extensive dominance. Compared with no genetic testing, multigene testing for all BC ...

The Cost-Effectiveness of Multigene Panel Testing for Hereditary ...

We use an economic decision model to assess whether the current knowledge on non-BRCA mutation prevalence, cancer risk, and patient preferences ...

Cost-effectiveness of BRCA1 testing at time of obstetrical prenatal ...

Among our cohort, BRCA1 testing resulted in the identification of an additional 3716 BRCA1-positive patients, the prevention of 1394 breast and ovarian cancer ...

(PDF) Cost-Effectiveness of Population-Based Multigene Testing for ...

Secondary outcomes included incremental cost, additional breast and ovarian cancer cases prevented, and excess deaths due to coronary heart ...

Impact on costs and outcomes of multi-gene panel testing for ...

The general health-associated costs were higher for OCTANE patients with ovarian cancer (total cost: $21,697,945 vs. $12,819,247, mean cost: ...

Economic impact of multigene panel testing for hereditary breast ...

Among VUS patients in the panel and SS groups, mean all-cause costs were US$14,404 versus US$20,607 (p = 0.361) and mean risk-reduction/early ...

All Women with Breast Cancer Should Undergo Multigene Testing ...

BRCA1/BRCA2/PALB2 multigene testing for all patients detected with BC would cost between $61,618 and $65,661 per QALY in the United States ...

Multigene Testing in Breast Cancer: Cost-effectiveness Analysis

According to analyses, unselected multigene testing was very cost-effective and, based on their data, could prevent thousands of cases of cancer ...